Advertisement

Topics

MaxCyte, Inc Company Profile

08:34 EST 15th December 2018 | BioPortfolio

MaxCyte is a clinical-stage cell therapeutics company with a growing pipeline of proprietary and partnered drug candidates. Programs in development are based on MaxCyte's platform technology which breaks down the barriers to ex vivo cell loading and the manufacture of viral vectors. MaxCyte's pipeline includes one product in Phase I/II clinical trials for the treatment of Chronic Lymphocytic Leukemia (CLL) and several preclinical candidates to treat a variety of diseases with unmet needs. The company also offers its unparalleled, customizable technology to collaborators who take advantage of its advanced capabilities for cell-based therapeutic development and biotherapeutic manufacturing. Partners are currently working to develop therapeutics for pulmonary disease, congenital heart disease and cancer

Location

22 Firstfield Road, Suite 250
Gaithersburg
Maryland
20878
United States of America

Contact

Phone: 301-944-1700
Fax: (301) 944-1703
Email: info@maxcyte.com


News Articles [28 Associated News Articles listed on BioPortfolio]

MaxCyte updates on plans to simplify share structure

MaxCyte currently has two classes of shares: unrestricted and Regulation S restricted

MaxCyte starts dosing in Phase I trial of MCY-M11

MaxCyte has dosed the first patient in a Phase I clinical trial to evaluate the safety and effectiveness of intraperitoneal...Read More... The post MaxCyte starts dosing in Phase I trial of MCY-M11 ap...

CRISPR and MaxCyte sign licensing deal for cancer therapies

Swiss gene editing firm CRISPR Therapeutics has signed a non-exclusive commercial licence agreement with US-based drug maker MaxCyte for the...Read More... The post CRISPR and MaxCyte sign licensing d...

Precision, MaxCyte Enter Clinical Agreement

Allows Precision to use MaxCyte's Flow Electroporation® technologies to robustly deliver ARCUS genome-editing technology

MaxCyte begins dosing in phase I solid tumors clinical trial

The study is designed to evaluate MCY-M11, a mesothelin targeting CAR, in individuals with relapsed/refractory ovarian cancer and peritoneal mesothelioma. MaxCyte CEO Doug Doerfler said: “The in...

CRISPR, MaxCyte expand partnership into immuno-oncology

The companies have entered into a non-exclusive commercial license agreement that will allow CRISPR Therapeutics to deploy MaxCyte’s Flow Electroporation Technology to develop CRISPR/Cas9-based ther...

MaxCyte on track to start first-ever clinical trial before the end of the year

The phase I clinical study will evaluate the safety of MaxCyte's MCY-M11 chimeric antigen receptor in people with relapsed or difficult-to-treat ovarian cancer and peritoneal mesothelioma

MaxCyte receives FDA approval to start Phase I study of MCY-M11

MaxCyte has received investigational new drug (IND) approval from the US Food and Drug Administration (FDA) to initiate a Phase...Read More... The post MaxCyte receives FDA approval to start Phase I s...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

MaxCyte, Inc.

MaxCyte specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of innovative therapeutic products. Drawing on its cell the...

MaxCyte, Inc

MaxCyte is a clinical-stage cell therapeutics company with a growing pipeline of proprietary and partnered drug candidates. Programs in development are based on MaxCyte's platform technology which bre...

MEDINET Co., Ltd. and MaxCyte, Inc.

MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technol...

More Information about "MaxCyte, Inc" on BioPortfolio

We have published hundreds of MaxCyte, Inc news stories on BioPortfolio along with dozens of MaxCyte, Inc Clinical Trials and PubMed Articles about MaxCyte, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MaxCyte, Inc Companies in our database. You can also find out about relevant MaxCyte, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record